首页> 美国卫生研究院文献>Malaria Journal >Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi
【2h】

Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi

机译:用强效TLR佐剂配制的用于速尿和子孢子的细胞穿越蛋白(CelTOS)诱导高亲和力抗体可抑制斯蒂芬按蚊中的恶性疟原虫感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BackgroundPlasmodium falciparum parasite is the most deadly species of human malaria, and the development of an effective vaccine that prevents P. falciparum infection and transmission is a key target for malarial elimination and eradication programmes. P. falciparum cell-traversal protein for ookinetes and sporozoites (PfCelTOS) is an advanced vaccine candidate. A comparative study was performed to characterize the immune responses in BALB/c mouse immunized with Escherichia coli-expressed recombinant PfCelTOS (rPfCelTOS) in toll-like receptor (TLR)-based adjuvants, CpG and Poly I:C alone or in combination (CpG + Poly I:C), followed by the assessment of transmission-reducing activity (TRA) of anti-rPfCelTOS antibodies obtained from different vaccine groups in Anopheles stephensi.
机译:背景恶性疟原虫是人类疟疾中最致命的物种,开发预防恶性疟原虫感染和传播的有效疫苗是消除疟疾和根除疟疾计划的关键目标。猪钩体和子孢子的恶性疟原虫细胞横穿蛋白(PfCelTOS)是一种先进的疫苗候选物。进行了一项比较研究,以表征在以Toll样受体(TLR)为基础的佐剂,CpG和Poly I:C(单独或组合使用)(CpG)中用大肠杆菌表达的重组PfCelTOS(rPfCelTOS)免疫的BALB / c小鼠的免疫反应+ Poly I:C),然后评估得自斯蒂芬按蚊不同疫苗组的抗rPfCelTOS抗体的传递减少活性(TRA)。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号